Media coverage
134
Media coverage
Title Noctrix Health Announces Successful Randomized Controlled Trial (RCT) Outcomes And FDA Marketing Authorization For Its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet PR Newswire Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Street Insider Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet BioSpace Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet InvestorsObserver Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Finanzen.net Country/Territory Germany Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Yahoo! Finance Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet TickerTech.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet TD Ameritrade Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet ADVFN US Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Greenville Business Magazine Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Spoke.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet BluegrassLive.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Hopedale - Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet L' Observateur Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Ashland - Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Norwood - Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Salisbury Post Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Riverton Journal Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Smithfield Times Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Suffolk News Herald Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Leesville Leader Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Clemmons Courier Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet TheTidewaterNews.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet NorfolkWrentham - Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Chester County Press (Oxford, Pennsylvania) Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Elizabethton.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Gates County Index Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Times of San Diego Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Winchester Sun Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Luverne Journal Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Jessamine Journal Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic... Media name/outlet Franklin- Local Town Pages Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Media name/outlet Port Arthur News Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet INFORMNNY.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet VB Profiles Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WTVW FOX 7 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KODE TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Valleycentral.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WIAT TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet 8 News Now Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet LocalSRY.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WTWO Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Fox8 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KELOLAND TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WNTZ Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Siouxland Matters Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WANE-TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WJET Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WYZZ-TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet CBS17.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WHNT-TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet ConchoValleyHomepage.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet PIX11 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Texomashomepage.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet CNYHomepage.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WYTV News Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Fox 16 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Everything Lubbock Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet YourCentralValley.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KRQE Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WIVB Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WETM 18 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WPRI Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WJMN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WIProud.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WGN-TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet FOX 59 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KNWA Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet MyStateLine.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WSAV Country/Territory Georgia Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Binghamton Homepage Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WSPA.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet FOX 31 News KDVR Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WOWK Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WWLP.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WJTV.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KSNT TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KHON 2 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet FOX5 San Diego Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WesternSlopeNow.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KRON4 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet CW39 NewsFix Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Big Country Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Myarklamiss.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WYOU Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet YOUR BASIN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WRIC TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WVNS Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Kark.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KXNet.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet MyPanhandle.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WLNS Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KLFY Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WeAreGreenBay.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KSN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WRBL-TV Country/Territory Georgia Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WJHL.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WKRN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet CBS4Indy Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WBTW News13 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WJBF-TV Country/Territory Georgia Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WATE Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KOIN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet FOX8 WGHP Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Wavy Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WBOY Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WDHN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet CW33 NewsFix Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WNCT Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WKRG Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Fox 4 WDAF TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WTen.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Fox40 KTXL Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet OzarksFirst.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet NBC4 Columbus Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet ABC 4 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet Wood TV Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WDTN Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WFXRTV.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WCIA.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KTSM.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet My Champlain Valley Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet FOX21News.com Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WTRF Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet KGET Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WREG Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet ABC 27 Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy Media name/outlet WCBD Country/Territory United States Date 4/19/23 Persons Asim Roy Title Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for Media name/outlet User Walls Country/Territory United States Date 4/19/23 Persons Asim Roy